MEDINET Co., Ltd. (TYO:2370)
Japan · Delayed Price · Currency is JPY 30.00
0.00 (0.00%)
At close: Feb 6, 2026
MEDINET Market Cap
MEDINET has a market cap or net worth of 7.94 billion as of February 6, 2026. Its market cap has decreased by -14.22% in one year.
Market Cap
7.94B
Enterprise Value
n/a
Revenue
998.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.00
Market Cap Chart
Since December 20, 2005, MEDINET's market cap has decreased from 41.58B to 7.94B, a decrease of -80.90%. That is a compound annual growth rate of -7.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 7.94B | 3.45% |
| Dec 30, 2025 | 7.68B | -19.38% |
| Dec 30, 2024 | 9.52B | -11.95% |
| Dec 29, 2023 | 10.81B | -28.06% |
| Dec 30, 2022 | 15.03B | 64.34% |
| Dec 30, 2021 | 9.15B | -8.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 8.76B |
| CellSource | 8.27B |
| K Pharma,Inc. | 7.99B |
| ADR120S | 7.75B |
| Chiome Bioscience | 7.73B |
| BrightPath Biotherapeutics | 7.68B |
| OncoTherapy Science | 7.53B |
| Linical | 7.09B |